ETEX Corp. inked a non-exclusive deal with an Indiana company to distribute a bone putty used in spinal fusion treatments.
OrthoPediatrics Corp. will sell the Cambridge, Mass.-based company’s nanocrystalline calcium phosphate into the pediatric market in the U.S. and Canada. The product is used in spinal fusion procedures to fill bone voids or skeletal defects "that are not intrinsic to the stability of the bone structure," according to a press release.
ETEX makes a trio of bone products: EquivaBone, a moldable, injectable putty made of nanocrystalline calcium phosphate and demineralized bone matrix used in posterolateral spine fusion procedures; Beta-bsm, an injectable paste; and a moldable putty called Gamma-bsm. The latter two are designed to create a scaffold to promote new bone growth, according to the press release.
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.